{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T09:11:43Z","timestamp":1792746703151,"version":"4.5.0"},"reference-count":54,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T00:00:00Z","timestamp":1641945600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sexual Medicine Reviews"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.sxmr.2021.12.004","type":"journal-article","created":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T22:37:35Z","timestamp":1644532655000},"page":"255-262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Secnidazole for Trichomoniasis in Women and Men"],"prefix":"10.1093","volume":"10","author":[{"given":"Christina A.","family":"Muzny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia T.","family":"Van Gerwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1016\/j.sxmr.2021.12.004_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually transmitted infections treatment guidelines","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0002","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/cid\/ciy079","article-title":"Prevalence and correlates of trichomonas vaginalis infection among men and women in the United States","volume":"67","author":"Patel","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0003","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/cid\/ciab514","article-title":"Epidemiology, natural history, diagnosis, and treatment of Trichomonas vaginalis in men","volume":"73","author":"Van Gerwen","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0004","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1128\/JCM.00748-12","article-title":"Prevalence of Trichomonas vaginalis and coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in the United States as determined by the Aptima Trichomonas vaginalis nucleic acid amplification assay","volume":"50","author":"Ginocchio","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0005","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/AOG.0000000000003604","article-title":"Vaginitis in nonpregnant patients: ACOG practice bulletin, number 215","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0006","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1086\/338399","article-title":"Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus","volume":"34","author":"Moodley","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogoh.2021.102176","article-title":"Characteristics of pelvic inflammatory disease caused by sexually transmitted disease - an epidemiologic study","volume":"50","author":"Yagur","year":"2021","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0008","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejogrb.2018.06.031","article-title":"Trichomonas vaginalis infection-associated risk of cervical cancer: a meta-analysis","volume":"228","author":"Yang","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0009","first-page":"85","article-title":"Frequency of Trichomonas vaginalis infection in couples with fertility problems","volume":"54","author":"Rivero","year":"2002","journal-title":"Rev Cubana Med Trop"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0010","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s15010-015-0860-0","article-title":"Trichomonas vaginalis: Pathogenicity and potential role in human reproductive failure","volume":"44","author":"Mielczarek","year":"2016","journal-title":"Infection"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0011","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00007435-199707000-00008","article-title":"Trichomonas vaginalis associated with low birth weight and preterm delivery. The vaginal infections and prematurity study group","volume":"24","author":"Cotch","year":"1997","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0012","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/OLQ.0000000000000134","article-title":"Trichomonas vaginalis as a cause of perinatal morbidity: a systematic review and meta-analysis","volume":"41","author":"Silver","year":"2014","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0013","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1111\/1471-0528.16774","article-title":"Trichomoniasis adverse birth outcomes: a systematic review and meta-analysis","volume":"128","author":"Van Gerwen","year":"2021","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0014","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1086\/511278","article-title":"Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition","volume":"195","author":"McClelland","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0015","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/sextrans-2012-051005","article-title":"Trichomoniasis and HIV interactions: a review","volume":"89","author":"Kissinger","year":"2013","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0016","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00007435-199503000-00003","article-title":"Trichomoniasis in men: old issues and new data","volume":"22","author":"Krieger","year":"1995","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0017","doi-asserted-by":"crossref","first-page":"e90548","DOI":"10.1371\/journal.pone.0090548","article-title":"Epidemiology of undiagnosed trichomoniasis in a probability sample of urban young adults","volume":"9","author":"Rogers","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0018","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/OLQ.0b013e3181b38a4b","article-title":"Trichomoniasis and other sexually transmitted infections: results from the 2001-2004 national health and nutrition examination surveys","volume":"36","author":"Allsworth","year":"2009","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0019","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s11908-013-0325-5","article-title":"Mixed vaginitis-more than coinfection and with therapeutic implications","volume":"15","author":"Sobel","year":"2013","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0020","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.idc.2013.06.003","article-title":"Trichomoniasis: the \"neglected\" sexually transmitted disease","volume":"27","author":"Meites","year":"2013","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0021","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/cid\/ciy085","article-title":"Why does trichomonas vaginalis continue to be a \"Neglected\" sexually transmitted infection?","volume":"67","author":"Muzny","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0022","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1086\/509934","article-title":"Trichomonas vaginalis infection: The most prevalent nonviral sexually transmitted infection receives the least public health attention","volume":"44","author":"Van der Pol","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0023","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2217\/fmb-2017-0270","article-title":"Secnidazole: Next-generation antimicrobial agent for bacterial vaginosis treatment","volume":"13","author":"Nyirjesy","year":"2018","journal-title":"Future Microbiol"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0024","doi-asserted-by":"crossref","first-page":"e1282","DOI":"10.1093\/cid\/ciab242","article-title":"Efficacy and safety of single oral dosing of secnidazole for trichomoniasis in women: results of a phase 3, randomized, double-blind, placebo-controlled, delayed-treatment study","volume":"73","author":"Muzny","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0025","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2165\/00003495-199651040-00007","article-title":"Secnidazole: a review of its antimicrobial activity, pharmacokinetic properties and therapeutic use in the management of protozoal infections and bacterial vaginosis","volume":"51","author":"Gillis","year":"1996","journal-title":"Drugs"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0026","unstructured":"Faught BM, Harris K. The history of Secnidazole. Available at: https:\/\/www.npwomenshealthcare.com\/history-of-secnidazole\/.2019. Accessed September 1, 2021."},{"key":"10.1016\/j.sxmr.2021.12.004_bib0027","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/AOG.0000000000002135","article-title":"Secnidazole treatment of bacterial vaginosis: a randomized controlled trial","volume":"130","author":"Hillier","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2017.08.017","article-title":"A phase-3, double-blind, placebo-controlled study of the effectiveness and safety of single oral doses of secnidazole 2 g for the treatment of women with bacterial vaginosis","volume":"217","author":"Schwebke","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0029","first-page":"309","article-title":"Amoebecide and trichomonacide activities of secnidazole in the laboratory","volume":"69","author":"Benazet","year":"1976","journal-title":"Bull Soc Pathol Exot Filiales"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0030","first-page":"487","article-title":"[Comparative study for the evaluation of the efficacy and safety of metronidazole and secnidazole in the treatment of vaginal trichomoniasis]","volume":"65","author":"Buitron Garcia Figueroa","year":"1997","journal-title":"Ginecol Obstet Mex"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0031","doi-asserted-by":"crossref","first-page":"e02329","DOI":"10.1128\/AAC.02329-17","article-title":"In vitro study of the susceptibility of clinical isolates of trichomonas vaginalis to Metronidazole and Secnidazole","volume":"62","author":"Ghosh","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0032","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00404-012-2251-4","article-title":"Efficacy of the Mentha crispa in the treatment of women with Trichomonas vaginalis infection","volume":"286","author":"Moraes","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0033","first-page":"621","article-title":"Trichomoniasis in non-gonococcic urethritis among male patients","volume":"24","author":"\u00d6zbilgin","year":"1994","journal-title":"J Egypt Soc Parasitol"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0034","first-page":"621","article-title":"[Study of serum concentrations and urinary excretion of secnidazole after oral administration in man. Comparison with tinidazole]","volume":"28","author":"Populaire","year":"1980","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0035","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/jac\/14.4.423","article-title":"A metronidazole-resistant strain of Trichomonas vaginalis and its sensitivity to Go 10213","volume":"14","author":"Ray","year":"1984","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0036","first-page":"77","article-title":"Secnidazole. A 5-nitroimidazole derivative with a long half-life","volume":"54","author":"Videau","year":"1978","journal-title":"Br J Vener Dis"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0037","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijgo.2005.10.012","article-title":"Short-term therapy for mixed vaginal infections","volume":"92","author":"Villagrana-Zesati","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0038","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0399-077X(77)80094-2","article-title":"La trichomonase urog\u00e9nitale. Essais d'un imidazole \u00e0 demi-vie longue: le secnidazole","volume":"7","author":"Siboulet","year":"1977","journal-title":"M\u00e9decine et Maladies Infectieuses"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0039","first-page":"287","article-title":"Secnidazole in complex treatment of patients with urogential trichomoniasis","volume":"1","author":"Dyudyun","year":"2016","journal-title":"Dermatovenerol Cosmetol Sexopathol"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0040","first-page":"476","article-title":"Tratamiento de la vaginitis por tricomonas, con secnidazol en dosis \u00fanica","volume":"5","author":"Bravo","year":"1978","journal-title":"Invest Med Int"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0041","first-page":"197","article-title":"Tratamento da tricomoniase com dose \u00fanica de secnidazol (14.539 R.P.)","volume":"34","author":"Piato","year":"1977","journal-title":"Rev Braz Med"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0042","first-page":"365","article-title":"Tratamento da tricomoniase \u00farogenital (ensaio clinico o 14.539 R.P.)","volume":"34","author":"Rocha","year":"1977","journal-title":"Rev Bras Med"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0043","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/cpdd.406","article-title":"Two phase 1, open-label, single-dose, randomized, crossover studies to assess the pharmacokinetics, safety, and tolerability of orally administered granules of secnidazole (2g) in healthy female volunteers under different administration conditions","volume":"7","author":"Pentikis","year":"2018","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0044","unstructured":"Lupin Pharmaceuticals Inc. Solosec (secnidazole): [package insert] 2021, Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/209363s000lbl.pdf. Accessed August 31, 2021."},{"key":"10.1016\/j.sxmr.2021.12.004_bib0045","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.chroma.2004.05.083","article-title":"Solvent-free microwave extraction of essential oil from aromatic herbs: Comparison with conventional hydro-distillation","volume":"1043","author":"Lucchesi","year":"2004","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0046","first-page":"238","article-title":"The activity of 1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole (R. P. 8823) against experimental Trichomonas vaginalis infections","volume":"96","author":"Cosar","year":"1959","journal-title":"Ann Inst Pasteur (Paris)"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0047","unstructured":"Inc. LP. Lupin announces FDA approval of supplemental new drug application for SOLOSEC\u00ae (secnidazole) for the treatment of trichomoniasis. Published 2021, Available at: https:\/\/www.lupin.com\/lupin-announces-fda-approval-of-supplemental-ne...lication-for-solosec-secnidazole-for-the-treatment-of-trichomoniasis\/. Accessed September 1, 2021."},{"key":"10.1016\/j.sxmr.2021.12.004_bib0048","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S1473-3099(18)30423-7","article-title":"Single-dose versus 7-day-dose metronidazole for the treatment of trichomoniasis in women: an open-label, randomised controlled trial","volume":"18","author":"Kissinger","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0049","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/OLQ.0000000000001178","article-title":"A narrative review of current challenges in the diagnosis and management of bacterial vaginosis","volume":"47","author":"Muzny","year":"2020","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0050","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/s12879-015-1055-0","article-title":"Trichomonas vaginalis: a review of epidemiologic, clinical and treatment issues","volume":"15","author":"Kissinger","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0051","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/01.olq.0000135990.21755.51","article-title":"Personal digital assistants used to document compliance of bacterial vaginosis treatment","volume":"31","author":"Bartley","year":"2004","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0052","unstructured":"Srinivasan S. An antimicrobial bioassay to assess adherence to metronidazole treatment for bacterial vaginosis. Oral Abstract #14, presented at the 2021 Infectious Diseases Society of Obstetrics and Gynecology Annual (Virtual) Meeting on July 29, 2021."},{"key":"10.1016\/j.sxmr.2021.12.004_bib0053","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1089\/jwh.2017.6500","article-title":"A phase 3, multicenter, prospective, open-label study to evaluate the safety of a single dose of secnidazole 2 g for the treatment of women and postmenarchal adolescent girls with bacterial vaginosis","volume":"27","author":"Chavoustie","year":"2018","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.sxmr.2021.12.004_bib0054","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1097\/OLQ.0000000000000959","article-title":"Is it time to stop using single-dose oral metronidazole for the treatment of trichomoniasis in women?","volume":"46","author":"Muzny","year":"2019","journal-title":"Sex Transm Dis"}],"container-title":["Sexual Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050052122000038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050052122000038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T19:38:15Z","timestamp":1672774695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2050052122000038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S2050052122000038"],"URL":"https:\/\/doi.org\/10.1016\/j.sxmr.2021.12.004","relation":{},"ISSN":["2050-0521"],"issn-type":[{"value":"2050-0521","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Secnidazole for Trichomoniasis in Women and Men","name":"articletitle","label":"Article Title"},{"value":"Sexual Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sxmr.2021.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of the International Society for Sexual Medicine.","name":"copyright","label":"Copyright"}]}}